Ensign Peak Advisors, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

$55.3 Billion
Q4 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 41,649 shares of REGN stock, worth $29.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

41,649

Previous 42,742 2.56%

Holding current value

$29.7 Million

Previous $44.9 Million 33.97%

% of portfolio

0.05%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$701.85 - $1046.91 $767,122 - $1.14 Million	-1,093 Reduced 2.56%	41,649 $29.7 Million
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $88 Million - $103 Million	-85,969 Reduced 66.79%	42,742 $44.9 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $3.95 Million - $4.79 Million	-4,471 Reduced 3.36%	128,711 $135 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $5.38 Million - $5.92 Million	-5,964 Reduced 4.29%	133,182 $128 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $8.91 Million - $10.1 Million	11,490 Added 9.0%	139,146 $122 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $2.08 Million - $2.54 Million	3,003 Added 2.41%	127,656 $105 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $53.3 Million - $63.2 Million	76,094 Added 156.7%	124,653 $89.6 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $1.56 Million - $1.9 Million	-2,298 Reduced 4.52%	48,559 $39.9 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $160,942 - $174,736	228 Added 0.45%	50,857 $36.7 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $5.44 Million - $6.86 Million	-9,475 Reduced 15.76%	50,629 $34.9 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $7.9 Million - $10.6 Million	14,405 Added 31.52%	60,104 $35.5 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $6.26 Million - $7.35 Million	-10,524 Reduced 18.72%	45,699 $31.9 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $18.3 Million - $22.6 Million	-33,665 Reduced 37.45%	56,223 $35.5 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $4.7 Million - $5.58 Million	-8,190 Reduced 8.35%	89,888 $54.4 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $2.01 Million - $2.38 Million	-4,258 Reduced 4.16%	98,078 $54.8 Million
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $15.7 Million - $19.3 Million	-35,203 Reduced 25.59%	102,336 $48.4 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $6.55 Million - $8.32 Million	-13,692 Reduced 9.05%	137,539 $66.4 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $2.38 Million - $2.87 Million	-4,366 Reduced 2.81%	151,231 $84.7 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $34.7 Million - $45.3 Million	70,382 Added 82.59%	155,597 $97 Million
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $14.3 Million - $21.1 Million	42,684 Added 100.36%	85,215 $41.6 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $11.7 Million - $16 Million	42,531 New	42,531 $16 Million

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Regeneron Pharmaceuticals, Inc. Transaction History